CXCR1/2 inhibitor Repertaxin enhanced chemotherapeutic efficacy of 5-fluorouracil in gastric cancer by attenuating cell proliferation, inducing apoptosis and suppressing malignant behavior (179). Here, CXCR1 is linked to gastric cancer.